Vienna, Austria

Erwin Paul Schreiner

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 115(Granted Patents)


Location History:

  • Gerasdorf, AT (1994)
  • 125/4/02 Vienna, AT (2009)
  • Wein, AT (2012)
  • Vienna, AT (1994 - 2015)

Company Filing History:


Years Active: 1994-2015

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: Erwin Paul Schreiner: Innovator in Cyclic Depsipeptides

Introduction

Erwin Paul Schreiner is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of medicinal chemistry, particularly in the development of cyclic depsipeptides. With a total of 11 patents, his work has implications for treating various diseases.

Latest Patents

Schreiner's latest patents focus on cyclic depsipeptides, which are compounds that have shown potential as inhibitors of kallikrein 7 and human neutrophil elastase. One of his applications details the structure of these cyclic depsipeptides and their derivatives, emphasizing their use in treating kallikrein-7 dependent diseases. Another patent specifically discusses the use of these cyclic depsipeptides to inhibit kallikrein 7, showcasing their therapeutic potential.

Career Highlights

Throughout his career, Erwin Paul Schreiner has worked with prominent organizations such as Novartis AG and The Scripps Research Institute. His innovative research has contributed to advancements in drug development and therapeutic applications.

Collaborations

Schreiner has collaborated with esteemed colleagues, including Kyriacos Costa Nicolaou and Wilhelm Stahl. These partnerships have further enriched his research and expanded the impact of his inventions.

Conclusion

Erwin Paul Schreiner's work in cyclic depsipeptides exemplifies the intersection of innovation and medicinal chemistry. His contributions continue to influence the field and hold promise for future therapeutic advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…